Investments in and Advances to Partially-Owned Affiliates

9 Months Ended

Sep. 30, 2012

Investments in and Advances to Partially-Owned Affiliates [Abstract]

Investments in and Advances to Partially-Owned Affiliates

(5)  Investments in and Advances to Partially-Owned Affiliates

            Investments in and advances to partially-owned affiliates consist primarily of the Company's equity interest in Zenara Pharma ("Zenara").  The Company recorded a loss of $613 and $1,466 for the three and nine months ended September 30, 2012, respectively, related to Zenara.  These amounts include amortization expense of $234 and $728, for the three and nine months ended September 30, 2012, respectively. The Company recorded a loss of $497 and $1,164 for the three and nine months ended September 30, 2011, respectively, related to Zenara.  These amounts include amortization expense of $283 and $853, for the three and nine months ended September 30, 2011, respectively.  In the first nine months of 2012, the Company advanced $868 to Zenara.

            Investments in and advances to partially-owned affiliates also includes a loss of $17 and a gain of $245 for the three and nine months ended September 30, 2012, respectively, related to an investment in a European joint venture.  In the first nine months of 2012, the Company advanced $453 to the European joint venture.